Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model. (2021)
Attributed to:
UK Biobank (core renewal)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-20-1237
PubMed Identifier: 33472890
Publication URI: http://europepmc.org/abstract/MED/33472890
Type: Journal Article/Review
Volume: 81
Parent Publication: Cancer research
Issue: 6
ISSN: 0008-5472